SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it has signed a multi-year collaboration agreement ...
Tandem Diabetes Care (NASDAQ: TNDM), a medical device company, has had a rough year. The company's shares are down by 43%. It might be tempting to consider the stock at current levels. If it can ...
Zacks Investment Research on MSN
Reasons to hold Tandem Diabetes stock in your portfolio for now
Tandem Diabetes Care, Inc.’s TNDM impressive product launches are expected to bolster growth in the upcoming quarters. A strong solvency looks encouraging. However, concerns loom over fierce ...
About Tandem Diabetes Care Inc. Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem ...
Tandem Diabetes Care, Inc. TNDM has witnessed strong momentum in the past year. Shares of the company have risen 45.7% compared with the industry’s 7.3% growth during the same time frame. The S&P 500 ...
“The strength of our first quarter performance was driven by more than 20% worldwide sales growth, including our highest quarter ever outside the United States,” said John Sheridan, president and ...
DelveInsight's Diabetes Care Devices Market Insights report provides the current and forecast market analysis, individual leading diabetes care devices companies' market shares, challenges, diabetes ...
Diabetes Care Devices Market Insights, Competitive Landscape, and Market Forecast - 2034” report provides the current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results